Search
for
Sort by
Research 241–270 of 1000+
- LB1680 Effects of ganoderma lucidum extract and its active component, ganoderic acid A on hair loss prevention
- Drug news and therapeutic news
- 583 Hair cycle regulation by a mitochondrially localized protein: Is MPZL3 a central component of the elusive hair cycle clock?
- Safety and efficacy of tavaborole (AN2690), a novel boron-based molecule, in 3 phase II trials for the topical treatment of toenail onychomycosis
- Development of phage-containing hydrogel for treating Enterococcus faecalis-infected wounds
- Placebo-controlled oral pulse prednisolone therapy in alopecia areata
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Anagen Effluvium after Therapeutic Scalp Surgery: Unreported Phenomenon
- Temperature-dependent phase transition microemulsions for enhanced transdermal delivery of finasteride and silodosin
- Multi-functional nanozyme-integrated astragalus polysaccharide hydrogel for targeted phased therapy in diabetic wound healing
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Low-Dose Flutamide (125 mg/Day) as Maintenance Therapy in the Treatment of Hirsutism
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- Clinical features, therapeutic outcomes and recovery period of long COVID
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE)
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- 1049 Novel strategy to promote hair follicle growth and stem cell activation in human male scalp skin: Targeting prolactin receptor with ABS-201
- Exosomes derived from platelet-rich plasma promote hair regeneration by regulating the SIRT1/FoxO3a pathway to alleviate oxidative stress